BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15831478)

  • 1. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
    Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
    Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of new p53 targets revealed by ChIP on chip experiments.
    Ceribelli M; Alcalay M; Viganò MA; Mantovani R
    Cell Cycle; 2006 May; 5(10):1102-10. PubMed ID: 16721047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters.
    Caretti G; Salsi V; Vecchi C; Imbriano C; Mantovani R
    J Biol Chem; 2003 Aug; 278(33):30435-40. PubMed ID: 12771133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
    Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
    J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.
    Testoni B; Mantovani R
    Nucleic Acids Res; 2006; 34(3):928-38. PubMed ID: 16473849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three CCAAT-boxes and a single cell cycle genes homology region (CHR) are the major regulating sites for transcription from the human cyclin B2 promoter.
    Wasner M; Haugwitz U; Reinhard W; Tschöp K; Spiesbach K; Lorenz J; Mössner J; Engeland K
    Gene; 2003 Jul; 312():225-37. PubMed ID: 12909359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest.
    Manni I; Mazzaro G; Gurtner A; Mantovani R; Haugwitz U; Krause K; Engeland K; Sacchi A; Soddu S; Piaggio G
    J Biol Chem; 2001 Feb; 276(8):5570-6. PubMed ID: 11096075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation.
    Di Agostino S; Strano S; Emiliozzi V; Zerbini V; Mottolese M; Sacchi A; Blandino G; Piaggio G
    Cancer Cell; 2006 Sep; 10(3):191-202. PubMed ID: 16959611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function.
    Salsi V; Caretti G; Wasner M; Reinhard W; Haugwitz U; Engeland K; Mantovani R
    J Biol Chem; 2003 Feb; 278(9):6642-50. PubMed ID: 12482752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters, via p53 C-terminal lysines.
    Basile V; Mantovani R; Imbriano C
    J Biol Chem; 2006 Jan; 281(4):2347-57. PubMed ID: 16293626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
    Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
    Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo.
    Li Q; Herrler M; Landsberger N; Kaludov N; Ogryzko VV; Nakatani Y; Wolffe AP
    EMBO J; 1998 Nov; 17(21):6300-15. PubMed ID: 9799238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription repression of a CCAAT-binding transcription factor CBF/HSP70 by p53.
    Chae HD; Yun J; Shin DY
    Exp Mol Med; 2005 Oct; 37(5):488-91. PubMed ID: 16264274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
    Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
    Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.
    Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY
    Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences.
    Müller GA; Heissig F; Engeland K
    Mol Biol Evol; 2007 Mar; 24(3):814-26. PubMed ID: 17205977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone acetyltransferase activity of PCAF cooperates with the brahma/SWI2-related protein BRG-1 in the activation of the enhancer A of the MHC class I promoter.
    Brockmann D; Lehmkühler O; Schmücker U; Esche H
    Gene; 2001 Oct; 277(1-2):111-20. PubMed ID: 11602348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
    Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
    Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation.
    Li S; Moy L; Pittman N; Shue G; Aufiero B; Neufeld EJ; LeLeiko NS; Walsh MJ
    J Biol Chem; 1999 Mar; 274(12):7803-15. PubMed ID: 10075672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.